Miki N, Ono M, Hizuka N, Aoki T, Demura H
Department of Medicine, Tokyo Women's Medical College, Japan.
J Clin Invest. 1992 Jul;90(1):113-20. doi: 10.1172/JCI115823.
Both thyroid hormone and hypothalamic growth hormone (GH)-releasing factor (GRF) facilitate pituitary somatotroph function. However, the pathophysiological role of thyroid hormone in GRF secretion is less well understood. Thyrotoxicosis, induced by administration of thyroxine (T4) in rats, inhibited both pituitary GH levels and immunoreactive GRF secretion from incubated hypothalamus. At the highest dose of T4 given for 12 d, GRF secretion and pituitary GH decreased by 50 and 39%, respectively. Hypothyroidism induced by thyroidectomy (Tx) enhanced GRF secretion approximately twofold while depleting pituitary GH by greater than 99%. Both of these hypothalamic and pituitary effects were reversed by replacement of T4 but not human GH for 7 or 14 d. Human GH was as potent as T4 in restoring decreased body weight gains or serum insulin-like growth factor-1 levels in Tx rats. These results indicate that at both physiological and pathological concentrations in serum, thyroid hormone acts as an inhibitory modulator of GRF secretion, probably not involving a feedback mechanism through GH. A biphasic effect of thyroid hormone on pituitary GH levels appears to derive from the difference in primary target tissues of hyper- and hypothyroidism, the hypothalamus and the pituitary, respectively.
甲状腺激素和下丘脑生长激素(GH)释放因子(GRF)均能促进垂体生长激素细胞的功能。然而,甲状腺激素在GRF分泌中的病理生理作用尚不太清楚。给大鼠注射甲状腺素(T4)诱导甲状腺毒症,可抑制垂体GH水平以及培养的下丘脑免疫反应性GRF的分泌。给予最高剂量的T4持续12天,GRF分泌和垂体GH分别下降50%和39%。甲状腺切除术(Tx)诱导的甲状腺功能减退使GRF分泌增加约两倍,同时垂体GH减少超过99%。通过补充T4而非人GH 7天或14天,可逆转下丘脑和垂体的这些效应。在恢复Tx大鼠体重增加减少或血清胰岛素样生长因子-1水平方面,人GH与T4的效力相当。这些结果表明,在血清的生理和病理浓度下,甲状腺激素均作为GRF分泌的抑制性调节因子,可能不涉及通过GH的反馈机制。甲状腺激素对垂体GH水平的双相作用似乎源于甲状腺功能亢进和减退的主要靶组织分别为下丘脑和垂体的差异。